Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-10-13 POYHONEN JOHN President & CCO Option exercise +1,250 36,492
2022-10-13 POYHONEN JOHN President & CCO Option exercise +4,564 41,056
2022-10-13 POYHONEN JOHN President & CCO Shares withheld for taxes −2,012 $3.76 $8K 39,044
2022-10-13 POYHONEN JOHN President & CCO Option exercise · Restricted Stock Units −1,250 10,000
2022-10-13 POYHONEN JOHN President & CCO Option exercise · Restricted Stock Units −4,564 37,064
2022-10-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +553 19,518
2022-10-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +1,932 21,450
2022-10-13 Peraza Lisa VP, Chief Accounting Officer Shares withheld for taxes −861 $3.76 $3K 20,589
2022-10-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −553 4,416
2022-10-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −1,932 15,694
2022-10-13 MANHARD KIMBERLY EVP, Drug Development Option exercise +1,250 15,924
2022-10-13 MANHARD KIMBERLY EVP, Drug Development Option exercise +4,564 20,488
2022-10-13 MANHARD KIMBERLY EVP, Drug Development Shares withheld for taxes −2,012 $3.76 $8K 18,476
2022-10-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −1,250 10,000
2022-10-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −4,564 37,064
2022-07-25 Szekeres David Leslie EVP, Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +165,961 165,961
2022-07-25 POYHONEN JOHN President & CCO Grant or award · Employee Stock Option (Right to Buy) +165,961 165,961
2022-07-25 Peraza Lisa VP, Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +60,902 60,902
2022-07-25 MANHARD KIMBERLY EVP, Drug Development Grant or award · Employee Stock Option (Right to Buy) +165,961 165,961
2022-07-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise +1,250 14,340

Page 19 of 28 · 557 trades